Advertisement

Ads Placeholder
Loading...

Delaware Thirteen Ltd

D13.AXASX
Financial Services
Financial - Mortgages
$0.04
$0.00(0.00%)
Australian Market opens in 44h 26m

Delaware Thirteen Ltd (D13.AX) Stock Competitors & Peer Comparison

See (D13.AX) competitors and their performances in Stock Market.

Peer Comparison Table: Financial - Mortgages Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
D13.AXA$0.04N/A22.3M-2.05-A$0.02N/A
HGH.AXA$0.99+1.54%935.8M14.14A$0.07+5.64%
AFG.AXA$1.82-1.36%494.6M12.13A$0.15+5.49%
RMC.AXA$0.90+0.00%354M7.46A$0.12+31.84%
YBR.AXA$0.06-6.15%20M-6.10-A$0.01N/A
N1H.AXA$0.10+0.00%8.8M10.00A$0.01+3.00%

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

D13.AX vs HGH.AX Comparison April 2026

D13.AX plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, D13.AX stands at 22.3M. In comparison, HGH.AX has a market cap of 935.8M. Regarding current trading prices, D13.AX is priced at A$0.04, while HGH.AX trades at A$0.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

D13.AX currently has a P/E ratio of -2.05, whereas HGH.AX's P/E ratio is 14.14. In terms of profitability, D13.AX's ROE is -1.54%, compared to HGH.AX's ROE of +0.07%. Regarding short-term risk, D13.AX is less volatile compared to HGH.AX. This indicates potentially lower risk in terms of short-term price fluctuations for D13.AX.Check HGH.AX's competition here

Stock price comparison of stocks in the Financial Services Sector

Loading...

Frequently Asked Questions